Figure 1From: Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial Trial Design: 4 parallel phase II double-blind placebo-controlled phase II trials. Back to article page